Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-009023)

Filing Details

Accession Number:: 0001127602-12-009023
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-01 18:35:30
Reporting Period:: 2012-03-01

Filing Date:: 2012-03-01
Accepted Time:: 2012-03-01 18:35:30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
318154	Amgen Inc	AMGN	Biological Products, (No Disgnostic Substances) (2836)	953540776

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1032669	Frank Biondi	One Amgen Center Drive Thousand Oaks CA 91320-1799		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-01	5,000	$58.61	31,188	No	4	M	Direct
Common Stock	Disposition	2012-03-01	5,000	$67.57	26,188	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nqso (Right to Buy)	Disposition	2012-03-01	5,000	$0.00	5,000	$58.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-03-15	2012-03-15	No	4	M	Direct

Footnotes

The price reported is an average price. The prices ranged from $67.56 to $67.58 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.